Related Experiment Video
Updated: Jul 14, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
Roundtable discussion: Incorporating bone marrow transplantation into NCCN guidelines
W P Vaughan1, S M Silver, P G Beatty
1Bone Marrow Transplantation Program, University of Alabama at Birmingham, USA.
A new National Comprehensive Cancer Network panel is standardizing bone marrow transplant guidelines. This ensures consistent, evidence-based use of autologous and allogeneic transplantation across cancer types, including hematologic malignancies and breast cancer.
Area of Science:
- Hematology
- Oncology
- Transplantation Medicine
Background:
- The National Comprehensive Cancer Network (NCCN) established a panel for bone marrow transplantation.
- The panel aims to integrate allogeneic and autologous transplantation into NCCN guidelines where evidence supports their use.
- Ensuring consistency in marrow transplantation recommendations across various cancer guidelines is a key objective.
Purpose of the Study:
- To review and ensure the appropriate inclusion of bone marrow transplantation in NCCN guidelines.
- To standardize the application of bone marrow transplantation across different hematologic malignancies and other cancers.
- To address the need for guideline updates reflecting emerging evidence, particularly for autologous bone marrow transplantation in breast cancer.
Main Methods:
- A preliminary review of existing NCCN guidelines was conducted.
- Assessment of the current evidence supporting bone marrow transplantation in various hematologic malignancies.
- Identification of areas requiring guideline refinement, such as lymphomas, multiple myeloma, and myelodysplasia.
Main Results:
- Bone marrow transplantation is appropriately included for common adult hematologic malignancies: acute myeloid leukemia, chronic myeloid leukemia, myelodysplasia, multiple myeloma, Hodgkin's disease, and malignant lymphomas.
- Refinements are needed for lymphomas, multiple myeloma, and myelodysplasia due to evolving data and definitions.
- Growing evidence for autologous bone marrow transplantation in advanced and metastatic breast cancer necessitates guideline updates.
Conclusions:
- The NCCN panel is working to standardize bone marrow transplantation guidelines.
- Guidelines require frequent updates to reflect the latest evidence, especially for complex hematologic conditions and breast cancer.
- Patient referral to well-designed clinical trials remains the standard of care for all bone marrow transplantations.
Related Concept Videos
Treatment Resistant Cancers
Regulation of Hematopoietic Stem Cells
Treatment Resistent Cancers
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

